Macrophages, PPARs, and Cancer

Macrophages, PPARs, and Cancer

Mononuclear phagocytes often function as control switches of the immune system, securing the balance between pro- and anti-inflammatory reactions. For this purpose and depending on the activating stimuli, these cells can develop into different subsets: proinflammatory classically activated (M1) or a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jo A. Van Ginderachter, Kiavash Movahedi, Jan Van den Bossche, Patrick De Baetselier
Format:	Article
Language:	English
Published:	Wiley 2008-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2008/169414
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ablation of NK Cell Function During Tumor Growth Favors Type 2-Associated Macrophages, Leading to Suppressed CTL Generation
by: Anja B. Geldhof, et al.
Published: (2003-01-01)

Redox Regulation of PPARγ in Polarized Macrophages
by: Verena Trümper, et al.
Published: (2020-01-01)

The Role of PPARs in Cancer
by: Keisuke Tachibana, et al.
Published: (2008-01-01)

PPARs and Gastrointestinal Cancer
by: Valerio Pazienza
Published: (2012-01-01)

PPAR Ligands for Cancer Chemoprevention
by: Yumiko Yasui, et al.
Published: (2008-01-01)

Enhancement of slow wave sleep in Alzheimer's disease by closed-loop acoustic stimulation
by: Maarten Van Den Bossche
Published: (2025-01-01)

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
by: Roberto Scatena, et al.
Published: (2008-01-01)

USP22 enhances atherosclerotic plaque stability and macrophage efferocytosis by stabilizing PPARγ
by: Senhu Tang, et al.
Published: (2025-04-01)

NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
by: Gerardo G. Mackenzie, et al.
Published: (2008-01-01)

PPARα- and DEHP-Induced Cancers
by: Yuki Ito, et al.
Published: (2008-01-01)

PPARs Signaling and Cancer in the Gastrointestinal System
by: Valerio Pazienza, et al.
Published: (2012-01-01)

PPARγ is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis.
by: Eusondia Arnett, et al.
Published: (2018-06-01)

Affinity is an important determinant of the anti-trypanosome activity of nanobodies.
by: Guy Caljon, et al.
Published: (2012-01-01)

Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines
by: Liudmyla Maksymova, et al.
Published: (2025-03-01)

Clinical Use of PPARγ Ligands in Cancer
by: Jennifer L. Hatton, et al.
Published: (2008-01-01)

Poissy (Yvelines). Les Terrasses de Poncy
by: Benjamin Van den Bossche, et al.
Published: (2019-12-01)

Rocquencourt (Yvelines). Le Bourg
by: Benjamin Van den Bossche, et al.
Published: (2012-12-01)

PPARS and Obesity
by: Francine M. Gregoire, et al.
Published: (2007-01-01)

Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
by: Melody Chiu, et al.
Published: (2017-01-01)

The Interplay between Metabolism, PPAR Signaling Pathway, and Cancer
by: Daniele Fanale, et al.
Published: (2017-01-01)

Current Understanding of the Role of PPARγ in Gastrointestinal Cancers
by: Bing Zou, et al.
Published: (2009-01-01)

PPAR in Cardiovascular Disorders
by: Alexander N. Orekhov, et al.
Published: (2016-01-01)

S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation
by: Xu Chen, et al.
Published: (2021-06-01)

PPAR-Gamma Agonist Pioglitazone Reduced CD68+ but Not CD163+ Macrophage Dermal Infiltration in Obese Psoriatic Patients
by: Ya. O. Yemchenko, et al.
Published: (2020-01-01)

The Crucial Role of the PPAR Signaling Pathway in the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: An Analysis of Gene Expression and Macrophage Polarization
by: Zhang L, et al.
Published: (2025-07-01)

PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells
by: William M. Wood, et al.
Published: (2011-01-01)

Genetic Variation of PPARs
by: Marie-Claude Vohl, et al.
Published: (2009-01-01)

PPARs and Liver Disease
by: Yasuteru Kondo, et al.
Published: (2013-01-01)

PPARs in Viral Disease
by: Jacqueline Capeau, et al.
Published: (2009-01-01)

PPARs and Anticancer Therapies
by: Michael E. C. Robbins, et al.
Published: (2010-01-01)

PPARs, Obesity, and Inflammation
by: Sander Kersten, et al.
Published: (2007-01-01)

PPARs and Bone Metabolism
by: Beata Lecka-Czernik
Published: (2006-01-01)

Metabolomics of the interaction between PPAR‐α and age in the PPAR‐α‐null mouse
by: Helen J Atherton, et al.
Published: (2009-04-01)

Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
by: Masahito Shimizu, et al.
Published: (2008-01-01)

PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs
by: Marion Peyrou, et al.
Published: (2012-01-01)

MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers
by: Dorothea Portius, et al.
Published: (2017-01-01)

CD97/ADGRE5 Inhibits LPS Induced NF-κB Activation through PPAR-γ Upregulation in Macrophages
by: Shuai Wang, et al.
Published: (2016-01-01)

CaF2 nanoparticles deliver siRNA targeting STAT6 and PPAR- γ to depolarise tumour-associated macrophages
by: Hamed Al-Busaidi, et al.
Published: (2025-01-01)

Modeling Moisture Accumulation and Decay Potential in Cross-Laminated Timber Wall Assemblies Exposed During the Construction Phase
by: Anke Blommaert, et al.
Published: (2025-03-01)

Dietary Modulation of Inflammation-Induced Colorectal Cancer through PPARγ
by: Ashlee B. Carter, et al.
Published: (2009-01-01)